Arvinas, Inc.

NASDAQ:ARVN

27.14 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 102.476.525.3-43.134.654.532.53830.331.324.226.39.2855.5445.5392.2187.5975.7486.244.89330.054.0164.0163.443.3753.44.1092.5721.6691.6691.669
Cost of Revenue 01.71.71.71.71.61.72.12.11.92.10.6690000000000000000000
Gross Profit 102.474.823.6-44.832.952.930.835.928.229.422.125.6319.2855.5445.5392.2187.5975.7486.244.89330.054.0164.0163.443.3753.44.1092.5721.6691.6691.669
Gross Profit Ratio 10.9780.9331.0390.9510.9710.9480.9450.9310.9390.9130.9751111111111111111111
Reseach & Development Expenses 86.993.784.395.285.9103.495.398.377.575.36461.840.60443.01134.86733.230.01323.41621.72720.41516.58816.00114.1914.56213.1510.3387.1446.697.2237.8247.056
General & Administrative Expenses 75.831.324.32722.625.724.915.12024.320.218.916.01214.41112.31912.2319.3328.8157.9257.2687.9576.4415.6415.8214.2841.581.2471.1890.8570.570.93
Selling & Marketing Expenses 0-1.7-1.7-1.7000000000000000000000000000
SG&A 75.829.622.625.322.625.724.915.12024.320.218.916.01214.41112.31912.2319.3328.8157.9257.2687.9576.4415.6415.8214.2841.581.2471.1890.8570.570.93
Other Expenses 0-0.10-0.100-1.10.6-0.2-0.1-0.10.7960.2191.2370.2481.1630.1440.3080.390.5950.4050.1920.243-0.3160.160.1310.1270.5530.00100
Operating Expenses 162.7123.3106.9120.5108.5129.1120.2113.497.599.684.280.756.61657.42247.18645.43139.34532.23229.65227.68324.54522.44119.83120.38417.43411.9178.3917.8798.088.3927.984
Operating Income -60.3-48.5-83.3-165.3-73.9-74.6-87.7-75.4-67.2-68.3-60-54.4-47.331-51.877-41.646-43.213-31.748-26.484-23.412-22.795.505-18.425-15.814-16.944-14.059-8.518-4.282-5.307-6.411-6.725-6.317
Operating Income Ratio -0.589-0.634-3.2923.835-2.136-1.369-2.698-1.984-2.218-2.182-2.479-2.068-5.098-9.357-7.518-19.486-4.179-4.608-3.752-4.6570.183-4.587-3.937-4.925-4.165-2.505-1.042-2.063-3.842-4.03-3.785
Total Other Income Expenses Net 11.713.51412.11096.56.33.21.71.10.7960.2191.2370.2481.1630.1440.3080.390.595-24.270.1920.243-0.3160.160.133-0.0690.5550.0020.0470.071
Income Before Tax -48.6-35-69.3-153.2-63.9-65.6-81.2-69.1-64-66.6-58.9-53-46.752-50.289-40.964-41.546-30.82-25.227-21.739-21.048-17.675-17.165-14.404-16.088-13.388-7.855-4.15-4.728-6.397-6.678-6.246
Income Before Tax Ratio -0.475-0.458-2.7393.555-1.847-1.204-2.498-1.818-2.112-2.128-2.434-2.015-5.035-9.07-7.395-18.734-4.057-4.389-3.484-4.301-0.588-4.274-3.586-4.676-3.966-2.31-1.01-1.838-3.833-4.002-3.743
Income Tax Expense 0.60.20.11.60.1-0.3-0.410.82.23.44.50.0680.2271.2450.264-1.790.160.3240.406-1.868-24.2470.215-1.593-1.3940.1720.1410.1380.5650.01300
Net Income -49.2-35.2-69.4-154.8-64-66.6-80.8-79.9-66.2-70-63.4-53-46.752-50.289-40.964-41.546-30.82-25.227-21.739-21.048-17.675-17.165-14.404-16.088-13.388-7.855-4.15-4.728-6.397-6.678-6.246
Net Income Ratio -0.48-0.46-2.7433.592-1.85-1.222-2.486-2.103-2.185-2.236-2.62-2.015-5.035-9.07-7.395-18.734-4.057-4.389-3.484-4.301-0.588-4.274-3.586-4.676-3.966-2.31-1.01-1.838-3.833-4.002-3.743
EPS -0.68-0.49-0.97-2.53-1.18-1.25-1.52-1.5-1.24-1.32-1.2-1-0.94-1.03-0.84-0.99-0.79-0.65-0.56-0.56-0.54-0.55-0.46-0.52-0.42-0.25-0.2-0.23-0.31-3.52-3.29
EPS Diluted -0.68-0.49-0.97-2.53-1.18-1.25-1.52-1.5-1.24-1.32-1.2-1-0.94-1.03-0.84-0.99-0.79-0.65-0.56-0.56-0.54-0.55-0.46-0.52-0.42-0.25-0.2-0.23-0.31-3.52-3.29
EBITDA -58.7-46.8-81.6-163.6-73.9-74.6-87.7-75.4-65.1-66.4-57.9-54.4-45.231-48.803-39.495-43.213-29.713-24.349-20.936-22.79-17.044-16.645-15.814-16.944-13.184-7.679-3.82-4.617-6.303-6.635-6.245
EBITDA Ratio -0.573-0.612-3.2253.796-2.136-1.369-2.698-1.984-2.149-2.121-2.393-2.068-4.871-8.802-7.13-19.486-3.911-4.236-3.355-4.657-0.567-4.144-3.937-4.925-3.906-2.259-0.93-1.795-3.777-3.976-3.742